JP2010273685A5 - - Google Patents

Download PDF

Info

Publication number
JP2010273685A5
JP2010273685A5 JP2010166570A JP2010166570A JP2010273685A5 JP 2010273685 A5 JP2010273685 A5 JP 2010273685A5 JP 2010166570 A JP2010166570 A JP 2010166570A JP 2010166570 A JP2010166570 A JP 2010166570A JP 2010273685 A5 JP2010273685 A5 JP 2010273685A5
Authority
JP
Japan
Prior art keywords
protein
antibody
seq
vertebrate
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010166570A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010273685A (ja
Filing date
Publication date
Priority claimed from US08/400,159 external-priority patent/US5869282A/en
Application filed filed Critical
Publication of JP2010273685A publication Critical patent/JP2010273685A/ja
Publication of JP2010273685A5 publication Critical patent/JP2010273685A5/ja
Withdrawn legal-status Critical Current

Links

JP2010166570A 1995-03-07 2010-07-23 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法 Withdrawn JP2010273685A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/400,159 US5869282A (en) 1991-12-11 1995-03-07 Nucleotide and protein sequences of the serrate gene and methods based thereon

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007260391A Division JP2008099687A (ja) 1995-03-07 2007-10-03 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013023179A Division JP2013150605A (ja) 1995-03-07 2013-02-08 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法

Publications (2)

Publication Number Publication Date
JP2010273685A JP2010273685A (ja) 2010-12-09
JP2010273685A5 true JP2010273685A5 (enExample) 2011-07-14

Family

ID=23582455

Family Applications (4)

Application Number Title Priority Date Filing Date
JP8527061A Withdrawn JPH11507203A (ja) 1995-03-07 1996-03-07 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法
JP2007260391A Withdrawn JP2008099687A (ja) 1995-03-07 2007-10-03 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法
JP2010166570A Withdrawn JP2010273685A (ja) 1995-03-07 2010-07-23 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法
JP2013023179A Withdrawn JP2013150605A (ja) 1995-03-07 2013-02-08 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP8527061A Withdrawn JPH11507203A (ja) 1995-03-07 1996-03-07 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法
JP2007260391A Withdrawn JP2008099687A (ja) 1995-03-07 2007-10-03 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013023179A Withdrawn JP2013150605A (ja) 1995-03-07 2013-02-08 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法

Country Status (11)

Country Link
US (1) US5869282A (enExample)
EP (1) EP0813545B1 (enExample)
JP (4) JPH11507203A (enExample)
AT (1) ATE442381T1 (enExample)
AU (1) AU718955B2 (enExample)
CA (1) CA2214830C (enExample)
DE (1) DE69638022D1 (enExample)
DK (1) DK0813545T3 (enExample)
ES (1) ES2333384T3 (enExample)
PT (1) PT813545E (enExample)
WO (1) WO1996027610A1 (enExample)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004924A (en) 1991-12-11 1999-12-21 Imperial Cancer Research Technology, Ltd. Protein sequences of serrate gene products
US5869282A (en) * 1991-12-11 1999-02-09 Imperial Cancer Research Technology, Ltd. Nucleotide and protein sequences of the serrate gene and methods based thereon
US20050112121A1 (en) * 1992-04-30 2005-05-26 Yale University Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
EP0861261B9 (en) 1995-06-28 2010-02-24 Imperial Cancer Research Technology Limited Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
US5780300A (en) * 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
US20050158859A1 (en) * 1995-09-29 2005-07-21 Yale University Manipulation of non-terminally differentiated cells using the Notch pathway
DE69635899T2 (de) * 1995-11-17 2006-11-23 Asahi Kasei Kabushiki Kaisha Polypeptid, das die differenzierung unterdrueckt
US6291210B1 (en) * 1996-07-16 2001-09-18 Asahi Kasei Kabushiki Kaisha Differentiation inhibitor
CA2271248C (en) * 1996-11-07 2009-08-11 Jonathan Robert Lamb Use of a notch ligand in immunotherapy
AU773479B2 (en) * 1996-11-07 2004-05-27 Lorantis Limited Notch
US6887475B1 (en) 1996-11-07 2005-05-03 Lorantis Limited Notch
GB9623236D0 (en) * 1996-11-07 1997-01-08 Imperial College Notch
WO1998051799A1 (en) 1997-05-14 1998-11-19 Asahi Kasei Kogyo Kabushiki Kaisha Novel differentiation inhibitor
US6136952A (en) * 1997-06-25 2000-10-24 University Of Washington Human jagged polypeptide, encoding nucleic acids and methods of use
US6436650B1 (en) 1997-07-23 2002-08-20 Yale University Activated forms of notch and methods based thereon
US6692919B1 (en) * 1997-07-23 2004-02-17 Yale University Activated forms of notch and methods based thereon
AU1054900A (en) * 1998-10-30 2000-05-22 Smith & Nephew Plc Compositions comprising notch receptor manipulating agents
US8084258B2 (en) * 1999-07-12 2011-12-27 University Of Basel Manipulation of tissue of organ type using the notch pathway
GB9927328D0 (en) 1999-11-18 2000-01-12 Lorantis Ltd Immunotherapy
US6984522B2 (en) * 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US8044259B2 (en) * 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
AU2001288628A1 (en) * 2000-08-31 2002-03-13 Loyola University Chicago Method and reagents for treatment of skin disorders by modulating the notch pathway
WO2002069369A2 (en) * 2000-12-08 2002-09-06 Coley Pharmaceutical Gmbh Cpg-like nucleic acids and methods of use thereof
GB0118155D0 (en) 2001-07-25 2001-09-19 Lorantis Ltd Superantigen
EP1410018A1 (en) * 2001-07-25 2004-04-21 Lorantis Limited Method for detecting modultators of notch signalling
CA2469204A1 (en) * 2001-12-07 2003-06-19 Regents Of The University Of Michigan Prospective identification and characterization of breast cancer stem cells
US20030185829A1 (en) * 2002-03-12 2003-10-02 Erich Koller Jagged 2 inhibitors for inducing apoptosis
US20040102401A1 (en) * 2002-11-22 2004-05-27 Isis Pharmaceuticals Inc. Modulation of jagged 1 expression
GB0300428D0 (en) * 2003-01-09 2003-02-05 Lorantis Ltd Medical treatment
GB0307472D0 (en) * 2003-04-01 2003-05-07 Lorantis Ltd Medical treatment
KR20060031809A (ko) * 2003-06-09 2006-04-13 더 리젠츠 오브 더 유니버시티 오브 미시간 암 치료 및 진단용 조성물 및 방법
JP2007526455A (ja) * 2004-02-03 2007-09-13 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 癌を特徴付ける、制御する、診断する、および処置するための組成物ならびに方法
US20060252073A1 (en) * 2005-04-18 2006-11-09 Regents Of The University Of Michigan Compositions and methods for the treatment of cancer
WO2006138275A2 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
AU2006308847C1 (en) * 2005-10-31 2012-05-10 Oncomed Pharmaceuticals, Inc. Compositions and methods for treating and diagnosing cancer
US7723477B2 (en) * 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
PT2500360E (pt) 2005-10-31 2015-10-15 Oncomed Pharm Inc Composições e métodos para diagnóstico e tratamento do cancro
WO2008121102A2 (en) * 2006-02-21 2008-10-09 The Regents Of The University Of Michigan Hedgehog signaling pathway antagonist cancer treatment
EP2106439B1 (en) * 2007-01-24 2014-11-12 The Regents of the University of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
EP2155249A4 (en) * 2007-05-15 2011-11-16 Oncomed Pharm Inc COMPOSITIONS AND METHOD FOR DIAGNOSIS AND TREATMENT OF CANCER
MX2011003183A (es) 2008-09-26 2011-04-21 Oncomed Pharm Inc Agentes que se unen a receptor encrespado y usos de los mismos.
US8945569B2 (en) 2009-11-19 2015-02-03 Oncomed Pharmaceuticals, Inc. Jagged-binding agents and uses thereof
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt拮抗劑及治療和篩選方法
KR20130043102A (ko) 2010-04-01 2013-04-29 온코메드 파마슈티칼스, 인크. 프리즐드-결합 작용제 및 그의 용도
EP2555781A1 (en) 2010-04-09 2013-02-13 Fred Hutchinson Cancer Research Center Compositions and methods for providing hematopoietic function
US20130095079A1 (en) 2010-04-09 2013-04-18 Fred Hutchinson Cancer Research Center Compositions and methods for providing hematopoietic function without hla matching
US9834755B2 (en) 2011-12-08 2017-12-05 Fred Hutchinson Cancer Research Center Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
CA2876904C (en) 2012-06-22 2019-12-03 Cytomx Therapeutics, Inc. Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
HK1212216A1 (en) 2012-10-23 2016-06-10 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using wnt pathway-binding agents
AU2014205662B2 (en) 2013-01-08 2019-09-05 Fred Hutchinson Cancer Research Center Compositions and methods for expansion of embryonic hematopoietic stem cells
HK1211887A1 (en) 2013-02-04 2016-06-03 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a wnt pathway inhibitor
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
AU2014342020C1 (en) 2013-10-31 2019-09-05 Fred Hutchinson Cancer Research Center Modified hematopoietic stem/progenitor and non-T effector cells, and uses thereof
JP6734283B2 (ja) 2015-01-21 2020-08-05 フレッド ハッチンソン キャンサー リサーチ センター 遺伝子治療用ポイントオブケア及び/又はポータブルプラットフォーム
JP6985934B2 (ja) 2015-04-29 2021-12-22 フレッド ハッチンソン キャンサー リサーチ センター 操作された造血幹細胞/前駆細胞及び非tエフェクター細胞、ならびにその使用
WO2016176652A2 (en) 2015-04-29 2016-11-03 Fred Hutchinson Cancer Research Center Modified stem cells and uses thereof
US10813949B2 (en) 2015-12-04 2020-10-27 Fred Hutchinson Cancer Research Center Uses of expanded populations of hematopoietic stem/progenitor cells
US11162071B2 (en) 2018-08-17 2021-11-02 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by upregulating JAG-1
WO2020037326A1 (en) 2018-08-17 2020-02-20 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating foxo
CN112680471B (zh) * 2019-10-17 2023-08-01 华南农业大学 ZmSPL基因在调控玉米柱头乳突细胞发育中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4795699A (en) 1987-01-14 1989-01-03 President And Fellows Of Harvard College T7 DNA polymerase
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
IL101728A (en) * 1991-05-03 2007-08-19 Univ Yale Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them
WO1993012141A1 (en) * 1991-12-11 1993-06-24 Yale University Nucleotide and protein sequences of the serrate gene and methods based thereon
US5869282A (en) * 1991-12-11 1999-02-09 Imperial Cancer Research Technology, Ltd. Nucleotide and protein sequences of the serrate gene and methods based thereon
US5786158A (en) * 1992-04-30 1998-07-28 Yale University Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
DE69635899T2 (de) * 1995-11-17 2006-11-23 Asahi Kasei Kabushiki Kaisha Polypeptid, das die differenzierung unterdrueckt
CA2256481A1 (en) * 1996-05-31 1997-12-04 The National American Red Cross Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
AU8003400A (en) * 1999-10-06 2001-05-10 Ansgar H. Santel Mitofusins, fzo homologs and functional derivatives thereof
JP5890756B2 (ja) 2012-06-28 2016-03-22 昭和電工株式会社 磁気記録媒体及び磁気記憶装置

Similar Documents

Publication Publication Date Title
JP2010273685A5 (enExample)
JP2017513479A5 (enExample)
JP2005120106A5 (enExample)
JP2012095652A5 (enExample)
JP2012522501A5 (enExample)
JP2011062217A5 (enExample)
JP2008538183A5 (enExample)
JP2016502512A5 (enExample)
JP2011224002A5 (enExample)
JP2007197439A5 (enExample)
JP2008525033A5 (enExample)
JP2013509879A5 (enExample)
JP2014506790A5 (enExample)
JP2019517799A5 (enExample)
MX346862B (es) Secuencias consenso de envoltura de vih y método para usar las mismas.
JP2014521313A5 (enExample)
JP2016530294A5 (enExample)
JP2012000112A5 (enExample)
JP2007530435A5 (enExample)
JP2013530689A5 (enExample)
JP2011004753A5 (enExample)
JP2012503478A5 (enExample)
JP2010142241A5 (enExample)
JP2010539926A5 (enExample)
HK1198170A1 (en) Pseudomonas exotoxin a with less immunogenic b cell epitopes